San Francisco 30 April 2019
The Report DNA and Gene Chip Market Analysis Report By Product (Consumables,
Instrumentation), By Application (Cancer Diagnosis & Treatment, Drug
Delivery, Genomics), By End Use, And Segment Forecasts, 2018 - 2025
The global DNA & gene chip market size is expected to reach USD 10.7 billion by 2025, according to a new report by Grand View Research, Inc., at an 11.4% CAGR during the forecast period. DNA and gene chips have gained much success in providing high throughput capabilities for comprehensive genome studies to enhance disease knowledge and target them. This technology has emerged as a valuable and promising solution across various aspects of disease management. These factors have been driving the market.
Conventional means of gene analysis allow
investigation of relatively small amounts of genes at a time, which further
emphasizes on the uptake of DNA microarray technology. DNA microarray
technology allows concurrent analysis of very large numbers of nucleic acid
fragments in a single experiment.
Continuous development of new tools to
support and enhance reliability of DNA microarray technology is likely to drive
this market at a significant pace in the foreseeable future. Furthermore,
healthcare entities are engaged in exploiting novel solutions for enhancing and
combining data generated from gene chip with data generated from high
throughput technologies. Mutually beneficial partnerships between microarray
developers and pharmaceutical/biopharmaceutical companies for acceleration of
genomic and biomedical research activities is anticipated to spur market growth
in the coming years.
Access Research Report of DNA & Gene Chip Market @ https://www.grandviewresearch.com/industry-analysis/dna-gene-chip-market
Further key findings from the report suggest:
· Based on product, consumables dominated the
market with the largest share. This is due to presence of large number of
entities engaged in providing reagents and kits associated with the use of DNA
chips
· The cancer treatment and diagnosis segment
accounts for a significant share in the market owing to rising inclination
toward development of companion diagnostics and growing usage of DNA
microarrays in cancer diagnosis and treatment
· Implementation of gene chip for drug
discovery is also expected to increase in the coming years owing to growing
demand for personalized medicine
· By end use, academic/government research
institutes accounted for the largest share in 2017. Ongoing research projects
on gene expression analysis in these institutes have attributed for the
estimated share
· In terms of region, North America dominated
the market with by revenue. High penetration of major revenue generating
companies in U.S. has contributed to its leading share
· Asia Pacific is projected to witness the
fastest year-on-year growth owing to rising healthcare spending in developing
economies and increase in R&D investment
· Some of the prominent market participants
are Agilent Technologies; Thermo Fisher Scientific, Incorporated (Affymetrix,
Inc.); Illumina, Inc.; Macrogen Inc.; and Arrayit Corporation. These players
are engaged in mutual partnerships with research communities and other
diagnostic firms for use of gene chips for targeting disease prognosis.
Browse more reports of this category by Grand View
Research at: https://www.grandviewresearch.com/industry/biotechnology
Grand View Research has
segmented the global DNA & gene chip market on the basis of application,
product, end use, and region:
DNA & Gene Chip Application Outlook
(Revenue, USD Million, 2014 - 2025)
·
Cancer diagnosis and treatment
·
Gene expression
·
Genotyping
·
Genomics
·
Drug discovery
·
Agricultural biotechnology
·
Others
DNA & Gene Chip Product Outlook
(Revenue, USD Million, 2014 - 2025)
·
Consumables
·
Instrumentation
DNA & Gene Chip End-use Outlook
(Revenue, USD Million, 2014 - 2025)
·
Academic & Government Research
Institutes
·
Hospitals & Diagnostics Centers
·
Biotechnology & Pharmaceutical
Companies
·
Others
DNA & Gene Chip Regional Outlook
(Revenue, USD Million, 2014 - 2025)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East & Africa
Access Press Release of
DNA & Gene Chip Market@ https://www.grandviewresearch.com/press-release/global-dna-gene-chip-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
